HomeOpen Access NewsResearch & Innovation

Research & Innovation

UK invests £75.6 million in a mission to clean up space debris

The UK Space Agency has announced a new initiative aimed at addressing the growing issue of space debris, launching a £75.6 million procurement process.

Rotating Lepton Model: Coupling relativity, quantum mechanics and neutrinos for the synthesis of matter

Professor Costas Vayenas and his coworkers Dionysios Tsousis and Dimitrios Grigoriou, discuss how using special relativity to study neutrino motion at fm distances leads to Bohr type models with relativistic gravity as the attractive force.

Bridging the gap between academic research and industrial application

Open Access Government talk to Vestas aircoil A/S about the multidisciplinary InDEStruct Project, and why it is vital that academia meets industry from the perspective of Industry 4.0.

Classical simulation of quantum circuits

Robert Wille, Professor at the Technical University of Munich and CSO at the Software Competence Center, Hagenberg, considers the classical simulation of quantum circuits

Canada: Supporting research coast-to-coast Innovation, Science & Economic Development

Canada (ISED) works in all areas of the economy and in all parts of the country to improve conditions for investment, enhance innovation performance, increase Canada’s share of global trade and build a fair, efficient and competitive marketplace.

NIST: Advancing innovation for quality of life

The National Institute of Standards & Technology works to promote U.S. innovation and industrial competitiveness by advancing measurement science, standards and technology to enhance economic security and improve quality of life.

The challenge of space debris: Near-Earth and Cislunar

The COSPAR Panel on Potentially Environmentally Detrimental Activities in Space (PEDAS) raise awareness of the human footprint on space, particularly the resulting space debris.

How can technological solutions enhance responses to terrorism?

Naz Dossa, CEO, Peoplesafe, explores how the Peoplesafe Alert service can enhance public safety through improved responses to terrorism.

Sex, language & coevolving informatics

Chris Girard, Associate Professor at Florida International University, shares his expertise on sex, language & coevolving informatics.

Finding innovative ways to deal with bacteria

Professor of Evolutionary Biology Ashleigh S. Griffin discusses harnessing the power of evolutionary process instead of fighting it, particularly regarding bacterial cells and cooperation.

ATTRACT as a funding experiment for innovation (3/4)

In two previous pieces from the October 2021 and January 2022 issues of Open Access Government, we have elaborated on how to extend the ATTRACT experiment into a sustainable tool for accelerating breakthrough innovation across Europe.

TheraVision: An oncolytic virus platform technology for a personalised virus-immunotherapy

Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.

Honeybee viral strains & transmission between honeybee colonies

Ivan Toplak, Professor from the University of Ljubljana, Veterinary Faculty, reveals what we know about honeybee viral strains and transmission between honeybee colonies.

Exosome therapy for brittle bone disease

Pascale V Guillot, Associate Professor at University College London, investigates the possibility of exosome therapy for those living with brittle bone disease.

Next generation sequencing in tissues: Towards in situ multiomics

Recent years have seen an increase in techniques developed for spatial transcriptomics, enabling gene expression patterns to be uncovered within intact, three-dimensional tissues.

Police do not consider 48% of autistic people to be vulnerable adults

The criminal justice system is failing autistic people, as clients are commonly not given support in trials because they are not deemed “vulnerable”.

Pfizer will donate profits from Russia to “humanitarian support”

Pfizer said all profits from Russia would go to "humanitarian support" for Ukraine, with future clinical trials now off the table.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders